Company news

Illumina, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Illumina Genomics Forum to Feature Bill Gates and Distinguished Health Leaders Addressing Need for Global Access to Genomics

August 7, 2022

Illumina Unveils its Most Accurate and Comprehensive Secondary Analysis Platform, Boosting Lab Capabilities

July 26, 2022

Illumina Announces Inaugural Illumina Genomics Forum with a Conversation with Former U.S. President Barack Obama

July 17, 2022

Illumina to Announce Second Quarter 2022 Financial Results on Thursday, August 11, 2022

July 13, 2022

Illumina Among First in the World to Receive Approval of Science-Based Net-Zero Target

July 13, 2022

Illumina Invests in £30M Venture Fund to Advance Breakthroughs in Human Health

June 27, 2022

Illumina Launches Research Test Codeveloped with Merck to Unlock Deeper Insights into the Tumor Genome

June 21, 2022

Joydeep Goswami appointed interim CFO; sam samad to depart Illumina

June 8, 2022

Illumina Announces Next Generation Products and Data at AGBT General Meeting to Advance Innovative Customer Solutions

June 6, 2022

Illumina to showcase the transformational impact of comprehensive genomic profiling in unlocking precision medicine for cancer patients, at ASCO

June 1, 2022

Illumina Introduces New Pan-Cancer Companion Diagnostic to Match Patients with Rare Genetic Mutations to Targeted Therapy

May 23, 2022

Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care

May 17, 2022

Illumina Reports Financial Results for First Quarter of Fiscal Year 2022

May 4, 2022

Illumina and Deerfield Management partner to accelerate drug development

May 4, 2022

Illumina Supports Leading German Hospital to Accelerate Genetic Disease Diagnosis in Critically Ill Children

April 24, 2022

Illumina to Announce First Quarter 2022 Financial Results on Thursday, May 5, 2022

April 13, 2022

Illumina Expands Access to Genomics in Latin America through New State-of-the-Art Solution Center

April 11, 2022

John Frank Joins Illumina as Chief Public Affairs Officer

April 10, 2022

Illumina Releases Annual Corporate Social Responsibility Report

April 6, 2022

Illumina Accelerator Invests in Seven Omics Startups Advancing Breakthrough Therapeutics, Diagnostics, DNA Storage, Mental Wellness, and Sustainable Foods Applications

March 15, 2022

Illumina Unveils Groundbreaking Comprehensive Genomic Profiling Test for Cancer in Europe

March 14, 2022

Illumina Welcomes Carissa Rollins as Chief Information Officer

March 13, 2022

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2021

February 9, 2022

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

February 2, 2022

Illumina collaborates with National Cancer Center Japan to address a leading cause of death in Asia

January 23, 2022

Illumina to Announce Fourth Quarter & Full Year 2021 Financial Results on Thursday, February 10, 2022

January 19, 2022

Illumina Partners with Agendia to Expand Genomic Testing in Breast Cancer Care

January 9, 2022

Illumina delivers 2021 results ahead of expectations, strong 2022 guidance and deep pipeline of long-term growth opportunities at 2022 J.P. Morgan Healthcare Conference

January 9, 2022

Illumina collaborates with Nashville Biosciences to accelerate medicines development

January 9, 2022

Illumina and Boehringer Ingelheim Announce Companion Diagnostic Partnership

January 9, 2022

Illumina Enters Co-Development Partnership with SomaLogic

January 4, 2022

Illumina and Syapse Partner on Research to Evaluate Large Panel Biomarker Testing Patterns Across US Community Oncology Practices

January 3, 2022

Illumina Supports Norway's Pioneering Precision Medicine Study

December 8, 2021

Illumina and Sequoia Capital China Select First Startups to join Genomics Incubator in China

November 16, 2021

Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease

November 15, 2021

Illumina Reports Financial Results for Third Quarter of Fiscal Year 2021

November 3, 2021

Illumina Supports Canada's Nationwide COVID-19 Genome Sequencing Initiative

November 2, 2021

Illumina Supports Israel's National Program to Accelerate Diagnoses of Critically-Ill Newborns with Suspected Genetic Disease

October 26, 2021

Illumina to Host Inaugural ESG Investor Event on Tuesday, November 16, 2021

October 19, 2021

Illumina Appoints Bob Ragusa as Chief Executive Officer (CEO) of GRAIL

October 13, 2021

Illumina to Announce Third Quarter 2021 Financial Results on Thursday, November 4, 2021

October 12, 2021

Illumina Expands Presence in Latin America

September 29, 2021

Randomized trial demonstrates whole-genome sequencing leads to precision care for critically ill infants

September 26, 2021

Illumina Ventures Closes $325 Million Fund

September 19, 2021

Illumina Accelerator Invests in Seven Genomics Startups for Third Global Cycle

September 14, 2021

Illumina Commits to Net Zero Global Greenhouse Gas Emissions by 2050

September 8, 2021

Illumina Partners with Merck to Develop and Commercialize Companion Diagnostic and Research Tests for Use in Identifying Specific Cancer Mutations

September 6, 2021

Illumina Acquires GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test

August 17, 2021

Illumina Reports Financial Results for Second Quarter of Fiscal Year 2021

August 4, 2021

Illumina Donates $1 Million in Sequencing Capabilities to Mumbai to Support Sequencing-Based COVID-19 Surveillance in India

August 3, 2021

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks

The 5 newest of 50 decks. Every deck is listed under its year.